There are other studies that have shown that metformin can reduce the content of SOD activity in GBM cells, resulting in a higher probability of GBM cells being exposed to oxygen-free radicals, suggesting that the inhibitory effect of metformin on GBM may be related to oxidative stress (51). This evidence concerns the gene SOD1 and glioblastoma.